MINK THERAPEUTICS INC

MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference

11 1月 2023 14:25:02 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference

17 11月 2022 09:00:01 条件 Nasdaq GlobeNewswire

MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline

10 11月 2022 09:05:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results

03 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update

20 10月 2022 09:00:01 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Host R&D Event November 10, 2022

05 10月 2022 09:16:53 条件 Nasdaq GlobeNewswire

MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

05 10月 2022 08:30:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Participate at Upcoming Investor Conferences

31 8月 2022 09:00:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results

09 8月 2022 08:00:02 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Participate at BTIG Biotechnology Conference

02 8月 2022 08:30:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update

27 7月 2022 08:30:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

25 5月 2022 08:30:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report

10 5月 2022 08:00:03 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update

27 4月 2022 17:19:52 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

18 3月 2022 08:30:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update

03 3月 2022 16:35:18 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers

03 3月 2022 09:28:47 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Participate at Upcoming B. Riley Securities Virtual Oncology Conference

12 1月 2022 09:41:30 条件 Nasdaq GlobeNewswire

MiNK Therapeutics to Participate in 4th Annual Evercore ISI HealthCONx Conference

17 11月 2021 16:15:00 条件 Nasdaq GlobeNewswire

MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797

12 11月 2021 07:00:01 条件 Nasdaq GlobeNewswire